Literature DB >> 10665778

Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan.

J Yan1, V Vetvicka, Y Xia, M Hanikýrová, T N Mayadas, G D Ross.   

Abstract

Liver macrophages (Kupffer cells) play a major role in blood clearance of both C3-opsonized immune complexes and therapeutic beta-glucan polysaccharides. Human Kupffer cells express three types of C3-receptors: CR1 (C3b-receptor; CD35), CR3 (iC3b- and beta-glucan-receptor), and CR4 (iC3b-receptor; CD11c/CD18). Studies of isolated macrophages have suggested that CR3 is the major receptor mediating capture of either C3-opsonized erythrocytes (E) or beta-glucans. In this investigation, the organ distribution and function of CR3 in the clearance of IgM-opsonized E and soluble CR3-binding polysaccharides were explored in normal vs. CR3-knockout (CR3-KO) mice. Analysis of intravenously (i.v.) injected 125I-anti-CR3 showed that the major vascular reservoir of CR3 was the liver, followed by spleen and lungs. By contrast, clearance of 125I-anti-CR1 appeared to be mediated predominantly by splenic B lymphocytes, as only subsets of splenic macrophages or Kupffer cells were found to express CR1. Clearance of IgM-opsonized 51Cr-E occurred rapidly to the livers of normal mice but was nearly absent in CR3-KO mice. Soluble 125I-beta-glucan exhibited rapid clearance to the liver in normal mice, whereas clearance in CR3-KO mice was significantly reduced. In conclusion, Kupffer cell CR3 plays a crucial role in the clearance of both IgM-opsonized E and beta-glucans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10665778     DOI: 10.1016/s0162-3109(99)00157-5

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  23 in total

Review 1.  Use of mouse models to study the mechanisms and consequences of RBC clearance.

Authors:  E A Hod; S A Arinsburg; R O Francis; J E Hendrickson; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2010-03-21       Impact factor: 2.144

2.  Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes.

Authors:  Rajesh Mukthavaram; Guixin Shi; Santosh Kesari; Dmitri Simberg
Journal:  J Control Release       Date:  2014-03-28       Impact factor: 9.776

3.  Structural transitions of complement component C3 and its activation products.

Authors:  Noritaka Nishida; Thomas Walz; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

4.  Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement.

Authors:  Zhili Xu; Jie Tian; Jeffrey S Smith; Andrew P Byrnes
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

5.  Molecular basis for complement recognition by integrin αXβ2.

Authors:  Xing Chen; Yamei Yu; Li-Zhi Mi; Thomas Walz; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

6.  Distearoyl anchor-painted erythrocytes with prolonged ligand retention and circulation properties in vivo.

Authors:  Guixin Shi; Rajesh Mukthavaram; Santosh Kesari; Dmitri Simberg
Journal:  Adv Healthc Mater       Date:  2013-06-25       Impact factor: 9.933

7.  Integrin αXβ₂ is a leukocyte receptor for Candida albicans and is essential for protection against fungal infections.

Authors:  Samir Jawhara; Elzbieta Pluskota; Dmitriy Verbovetskiy; Olena Skomorovska-Prokvolit; Edward F Plow; Dmitry A Soloviev
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

Review 8.  Herpes simplex virus as a tool to define the role of complement in the immune response to peripheral infection.

Authors:  Mark A Brockman; David M Knipe
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

Review 9.  Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy.

Authors:  Jingjing Liu; Lacey Gunn; Richard Hansen; Jun Yan
Journal:  Exp Mol Pathol       Date:  2009-01-21       Impact factor: 3.362

10.  Commandeering a biological pathway using aptamer-derived molecular adaptors.

Authors:  Prabhat K Mallik; Kimi Nishikawa; Albert J T Millis; Hua Shi
Journal:  Nucleic Acids Res       Date:  2010-01-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.